Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 20/20 | 0.86 |
| ▸ | CA2 | P00918 | 20/20 | 0.86 |
| ▸ | CA9 | Q16790 | 20/20 | 0.86 |
| ▸ | CA12 | O43570 | 12/20 | 0.83 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.83 |
| ▸ | CA4 | P22748 | 3/20 | 0.83 |
| ▸ | CA6 | P23280 | 3/20 | 0.83 |
| ▸ | CA7 | P43166 | 3/20 | 0.83 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.83 |
| ▸ | CA5A | P35218 | 2/20 | 0.83 |
| ▸ | CA3 | P07451 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14264259 | 0.91 | CA1 (0.76) | CA1CA2CA9CA12CA14 | |
| SCHEMBL18475432 | 0.87 | CA9 (1.00) | CA1CA2CA9CA12CA14 | |
| SCHEMBL2004300 | 0.86 | CA1 (0.69) | CA1CA2CA9CA12CA14 | |
| SCHEMBL28107398 | 0.84 | SOS1 (0.70) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1652316 | 0.82 | IKBKB (0.64) | CA1CA2CA9CA12CA14 | |
| SCHEMBL25147636 | 0.82 | CA9 (0.82) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13896222 | 0.82 | CA1 (0.68) | CA1CA2CA9CA12CA14 | |
| SCHEMBL30408661 | 0.82 | CA9 (0.82) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13752170 | 0.82 | CA1 (0.60) | CA1CA2CA9CA12CA14 | |
| SCHEMBL18475607 | 0.81 | CA9 (0.80) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656103-B2 | Light protecting-effective cosmetic or dermatological preparations | BASF SE (DE) | 2017-05-23 | — | — | US | disclosed |
| US-9656103-B2 | Light protecting-effective cosmetic or dermatological preparations | BASF SE (DE) | 2017-05-23 | — | — | US | disclosed |
| US-20080075746-A1 | Dispersing insoluble or sparingly soluble micronized substance in oil or water phase; adding soluble ultraviolet radiation filter that is not a cosmetic UV absorber; remarkable increase in (SPF) sun protection factor; sunscreen agents | CIBA SPECIALTY CHEMICALS CORPORATION | 2008-03-27 | — | — | US | disclosed |
| US-20080075746-A1 | Dispersing insoluble or sparingly soluble micronized substance in oil or water phase; adding soluble ultraviolet radiation filter that is not a cosmetic UV absorber; remarkable increase in (SPF) sun protection factor; sunscreen agents | CIBA SPECIALTY CHEMICALS CORPORATION | 2008-03-27 | — | — | US | disclosed |
| US-20070032381-A1 | Heat-sensitive recording material, heat-sensitive recording method and method for manufacturing heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2007-02-08 | — | — | US | disclosed |
| US-20070004594-A1 | Heat-sensitive recording material and heat-sensitive recording method | FUJI PHOTO FILM CO., LTD. | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080075746-A1 | Dispersing insoluble or sparingly soluble micronized substance in oil or water phase; adding soluble ultraviolet radiation filter that is not a cosmetic UV absorber; remarkable increase in (SPF) sun protection factor; sunscreen agents | CUTA, MITF, MIF | CA1 4703/4885CA2 4832/4885CA9 4282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.